71
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia

, , , , &
Pages 8025-8034 | Published online: 31 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yaru Zou, Dong Mei, Jinjie Yuan, Jiaqi Han, Jiamin Xu, Ning Sun, Huan He, Changqing Yang & Libo Zhao. (2021) Preparation, Characterization, Pharmacokinetic, and Therapeutic Potential of Novel 6-Mercaptopurine-Loaded Oral Nanomedicines for Acute Lymphoblastic Leukemia. International Journal of Nanomedicine 16, pages 1127-1141.
Read now

Articles from other publishers (9)

Reyhane Khademi, Zahra Mohammadi, Rahele Khademi, Amene Saghazadeh & Nima Rezaei. (2023) Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies. Nanoscale Advances 5:3, pages 571-595.
Crossref
Anton Tkachenko, Anatolii Onishchenko, Dmytro Butov & Maryna Tkachenko. (2022) FLOW CYTOMETRY IN NANOTOXICOLOGY: brief overview. Inter Collegas 8:4, pages 278-289.
Crossref
Zhenzhen Zhang, Xin Liu, Liyun Zhao, Yaru Zhou, Jianyou Shi, Weini Chen & Jinqi Li. (2022) A review on the treatment of multiple myeloma with small molecular agents in the past five years. European Journal of Medicinal Chemistry 229, pages 114053.
Crossref
Xiaofeng Dai, Danjun Wang & Jianying Zhang. (2021) Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis 26:7-8, pages 385-414.
Crossref
Paula M. Cevaal, Abdalla Ali, Ewa Czuba-Wojnilowicz, Jori Symons, Sharon R. Lewin, Christina Cortez-Jugo & Frank Caruso. (2021) In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design . ACS Nano 15:3, pages 3736-3753.
Crossref
Lizhen Liu, Sailan Liu, Peng Deng, Yujing Liang, Rong Xiao, Lin-Quan Tang, Jinghong Chen, Qiu-Yan Chen, Peiyong Guan, Shu-Mei Yan, Xiangliang Huang, Jing Han Hong, Jianfeng Chen, Yichen Sun, Bin Tean Teh, Qiang Yu, Hai-Qiang Mai & Jing Tan. (2021) Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma. Cancer Research 81:5, pages 1413-1425.
Crossref
Danielle M. Valcourt, Megan N. Dang, Mackenzie A. Scully & Emily S. Day. (2020) Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer. ACS Nano 14:3, pages 3378-3388.
Crossref
Zhu Xiufeng, Zhao Haijun, Bi Silei, Deng Manman, Zhou Yong, Yu Lian, Fang Zhihong & Xu Bing. (2019) Co-operation of ABT-199 and gemcitabine in impeding DNA damage repair and inducing cell apoptosis for synergistic therapy of T-cell acute lymphoblastic leukemia. Anti-Cancer Drugs 30:2, pages 138-148.
Crossref
Vaibhavi Peshattiwar, Aakruti Kaikini, Prajakta Dandekar, Padma V. Devarajan & Sadhana Sathaye. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis 483 519 .